about
A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and VomitingRecent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive reviewPattern of prophylaxis administration for chemotherapy-induced nausea and vomiting: an analysis of city-based health insurance data.Characteristics of communication guidelines that facilitate or impede guideline use: a focus group studyAntimicrobial prescribing in the USA for adult acute pharyngitis in relation to treatment guidelines.Aprepitant and fosaprepitant: a 10-year review of efficacy and safetyPharmaceutical care for patients with breast and ovarian cancerAssessing prescribing patterns for the prevention of chemotherapy-induced nausea and vomiting in the national center for cancer care and research.Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients.NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK.Management of chemotherapy-induced nausea and vomiting.Appropriate Use of Antiemetics to Prevent Chemotherapy-Induced Nausea and Vomiting.Antiemetic prophylaxis and frequency of chemotherapy-induced nausea and vomiting in palliative first-line treatment of colorectal cancer patients: the Northern Bavarian IVOPAK I Project.Adherence to antiemetic guidelines and control of chemotherapy-induced nausea and vomiting (CINV) in a large hospital.Evaluation of anti-emetic use in chemotherapy-induced nausea and vomiting in a third-world country (Lebanon).Changes in compliance with Japanese antiemetic guideline for chemotherapy-induced nausea and vomiting: a nationwide survey using a distributed research network.
P2860
Q26784064-ADB883C2-C071-4C3B-A62E-FF5F54EB7974Q28081186-0C92333A-1E57-4545-8B0A-2A1D4EB0C403Q30570659-B38D1585-5FB2-4D61-B99A-42BF74B86722Q33284815-2A4962F5-92ED-4C37-9893-AA1924722A3DQ34297797-5105154A-54FF-47B2-ABDC-32881887C01DQ35345557-FB5BF930-54A9-4981-BD65-FDE235787891Q36288172-1A4FCA9C-CF84-4635-A3F5-5D024884D288Q36806846-0D993D9C-7A73-453B-AE03-05F1847D6BE2Q37355479-C75E4768-D457-4098-9581-E44F3DB731CCQ37735410-5A31FD93-24DA-4CB1-9AD8-59506CB03872Q42786722-62C3958B-9ADA-4AA2-948A-E1441EE0361DQ46451199-A4712D41-1C4A-4061-92A1-A407FF8D86B7Q50860890-4D91C9CC-370A-4291-A65A-C7E0DE7F49F9Q51156164-51DBD9E9-16B8-4570-8A78-56677BC628ABQ51402096-8AA93A82-2F97-4199-8A73-3A4480E7111BQ54535398-DCACCEAF-890F-40D3-8401-756781A7DA5D
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Antiemetic guidelines: are they being used?
@ast
Antiemetic guidelines: are they being used?
@en
type
label
Antiemetic guidelines: are they being used?
@ast
Antiemetic guidelines: are they being used?
@en
prefLabel
Antiemetic guidelines: are they being used?
@ast
Antiemetic guidelines: are they being used?
@en
P1433
P1476
Antiemetic guidelines: are they being used?
@en
P2093
Rolf Kaiser
P304
P356
10.1016/S1470-2045(05)70284-9
P577
2005-08-01T00:00:00Z